Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11 clinical trials
Efficacy and Safety of CSA and Avatrombopag for the Treatment of SAA in the Elderly (SAA)

This is a multicenter, single-arm clinical study. The objective was to evaluate the efficacy and safety of CSA in combination with Avatrombopag in elderly patients with very/sever aplastic

  • 0 views
  • 10 Jul, 2022
  • 1 location
Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)

The purpose of this study is to determine if using avatrombopag in patients with thrombocytopenia due to temozolomide treatment can safely improve a patient's platelet count and allow the

  • 0 views
  • 30 Jun, 2022
  • 1 location
Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

A Phase 3b Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects with Immune Thrombocytopenia for ≥6 Months

avatrombopag
thrombocytopenia
  • 13 views
  • 21 Jul, 2022
  • 55 locations
Avatrombopag for Chemotherapy-induced Thrombocytopenia

To evaluate the efficacy and safety of Avatrombopag to treat chemotherapy-induced thrombocytopenia in solid tumors

  • 0 views
  • 23 Mar, 2022
  • 1 location
Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia

Avatrombopag in Patients with End-stage Liver Disease and Thrombocytopenia.

avatrombopag
platelet count
liver disease
cirrhosis
  • 0 views
  • 16 Jun, 2021
  • 1 location
Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

This prospective, open-label, single-center, one-arm clinical trial aims at evaluating the efficacy and safety of avatrombopag in Chinese adult Immune Thrombocytopenia (ITP) patients with

glucocorticoids
platelet count
evans syndrome
lupus
immune globulin
  • 0 views
  • 21 Jul, 2022
  • 1 location
Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure

In this study, investigators aimed to evaluate the efficacy of Avatrombopag in thrombocytopenic patients with chronic liver disease undergoing an elective invasive procedure through a

  • 0 views
  • 16 May, 2022
  • 1 location
Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment

This study aims to investigate the efficacy and safety of avatrombopag for treating thrombocytopenia in hepatitis b virus related acute-on-chronic liver failure patients receiving artificial

avatrombopag
  • 0 views
  • 06 Jun, 2022
  • 1 location
Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP

Evaluate the efficacy, safety, and PK of avatrombopag given for 26 weeks in Japanese adults with chronic immune thrombocytopenia (ITP).

  • 0 views
  • 26 Jul, 2022
Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Evaluate the safety and tolerability of avatrombopag given for 90 days after stopping treatment with eltrombopag or romiplostim.

avatrombopag
romiplostim
eltrombopag
thrombocytopenia
  • 0 views
  • 24 Jul, 2022
  • 13 locations